It has been available since 2021, providing a longer history of real-world use
GLP-1s slow the movement of food through the stomach and intestines, which is why the most common side effects are gastrointestinal: nausea, diarrhea, constipation and vomiting
By morning, the acute GI effects have typically subsided, and you wake up with the appetite suppression already active
Nitric oxide system interaction Research suggests BPC-157 may modulate the nitric oxide (NO) system, which plays a fundamental role in vascular function, inflammation, and cellular signalling
Research shows that Mounjaro, which has a dual GLP-1/GIP mechanism, promises even greater effectiveness
With proper guidance, it becomes a powerful tool in your long-term metabolic and body composition transformation